
zzso active and adoptive zzso of human zzso and zzso raise a renewed interest strengthened by the availability of zzso biological substances such as zzso zzso zzso hormones and by some recent zzso therapeutic results which have demonstrated the possibility of obtaining objective tumor zzso by zzso Analysis of results of chemotherapy shows that only 8 human zzso and zzso zzso are zzso at an advanced diffuse stage of zzso These zzso are characterized by the rarity or absence of late zzso (more than zzso years after initial zzso zzso may be considered as complete with a high probability if disease free status is maintained for 3 zzso This finding suggests the absence of tumor stem cells capable to produce late zzso Other zzso are not zzso at an advanced systemic zzso In most of them late zzso zzso than 4 years after zzso are zzso A model of organization of zzso tumors based on the distinction between primitive tumor stem cells which are rarely or exceptionally in cycle and protected by a specific zzso and committed tumor stem cells is zzso According to this model, only zzso and/or zzso and zzso zzso containing but committed tumor stem cells would be zzso Analysis of a trial of zzso therapy of breast cancer with zzso zzso zzso U shows the possibility of zzso to prevent the development of late zzso independently of hormonal status in contrast with standard zzso chemotherapy which is only active on early zzso in zzso zzso zzso AT 250 zzso 

